Ocrevus® (ocrelizumab)
for Multiple Sclerosis

Ocrevus (ocrelizumab) is a CD20-directed cytolytic antibody used to treat relapsing and progressive multiple sclerosis (MS) in adults, including primary progressive MS and relapsing forms like clinically isolated syndrome and active secondary progressive disease. It works by binding to and destroying B cells, which are involved in MS progression. By reducing B cells, Ocrevus helps reduce relapses, brain lesions, and disability progression.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Multiple Sclerosis - MS